The USPTO published a notice in the Federal Register that extends the period for public comment on deferred examination until May 29, 2009.  You now have plenty of time to put together that pithy memorandum with your thoughts on why the Patent Office should or should not park patent applications on a shelf for years […]

David Boundy, Vice President & Assistant General Counsel Intellectual Property at Cantor Fitzgerald LP , sent a note of importance to the patent community regarding a notice and comment period, which opened last week and closes on March 16, 2008  (See: Office of Management and Budget, Executive Office of the President, Request for Comment, 74 […]

Earlier, the Supreme Court ruled that MedImmune could sue Genentech for patent infringement even though MedImmune continued to pay licensing fees to Genentech to use disputed technology to develop the drug Synagis®.  At the same time, the U.S. Patent and Trademark Office decided to have a second review of the patents at issue, U.S. Pat. […]

The American Bar Association (ABA) Section of Intellectual Property Law has submitted comments to the Senate Judiciary Committee on the section’s policies relating to inequitable conduct before the U.S. Patent and Trademark Office.  The Section believes that the defense should be reformed and retained, rather than eliminated in favor of administrative proceedings in the PTO. […]

In response to suggestions from the intellectual property (IP) community that the USPTO adopt some form of a deferred examination procedure, the Patent Office will conduct a public roundtable discussion on the topic on Thursday, February 12, 2009, from 9 a.m.-12:30 p.m. at the agency’s headquarters in Alexandria, Virginia. The goal of the roundtable is […]

Earlier, the United States Patent and Trademark Office (USPTO) opened the patent examination process for online public participation. With the consent of the inventor, the Peer-to-Patent: Community Patent Review pilot, developed by the New York Law School Institute for Information Law and Policy in cooperation with the USPTO, enables the public to submit prior art […]

The U.S. Supreme Court is being asked to review a decision in a patent case which questions what things are patentable, including software and business strategies.  The applicants have filed a Petition for Writ of Certiorari to the Supreme Court to appeal from the U.S. Court of Appeals for the Federal Circuit in In re […]

James Greenwood, President & CEO of the Biotechnology Industry Organization (BIO), wrote an open letter to President-Elect Obama for his ideas on reform for the U.S. Patent and Trademark Office. With more than 1.2 million patent applications pending before its more than 6,000 examiners, there is a sense that something needs to give. Notably, the […]